7Miller R L,James-Kracke M,Sun G Y,Sun A Y. Oxidative and inflammatory pathways in Parkinson 's disease [ J ]. Neurochem Res, 2009,34( 1 ) :55 -65.
8Yuan W J, Yasuhara T, Shingo T, et al. Nenroprotective effects of edaravone - administration on 6-OHDA-treated dopaminergic neurons [ J ]. BMC Neurosci ,2008 ,9 : 75.
9Gomez-Lazaro M, Bonekamp N A, Galindo M F, et al. 6-hydroxydopamine (6-OHDA) induces Drpl-dependent mitochondrial fragmentation in SHSYSY cells[ J]. Free Radic Biol Med,2008,44 (11) :1960 -9.
10Simola N, Morelli M, Carta A R. The 6-hydroxydopamine model of Parkinson's disease[J]. Neurotox Res,2007,11(3-4) :151 -67.